1. J Thorac Dis. 2015 Mar;7(3):224-6. doi: 10.3978/j.issn.2072-1439.2015.01.47.

Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population 
advanced non-small cell lung cancer still matter of debate?-An update 
incorporating the DELTA trial data.

Garassino MC(1), Broggini M(1).

Author information:
(1)1 Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS 
Istituto Nazionale dei Tumori, Milan, Italy ; 2 Laboratory of Molecular 
Pharmacology, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, 
Italy.

DOI: 10.3978/j.issn.2072-1439.2015.01.47
PMCID: PMC4387444
PMID: 25922695